Furthermore, the administration of iron chelator deferoxamine to NRP1-deficient endosomal cells could restore mitochondrial function and rescue senescent phenotype (27), elucidating the promise of NRP1 as a therapeutic target for AD. The gene discussed is NRP1; the disease is Alzheimer disease.